Bedaiwi, Mohamed
Al-Homood, Ibrahim A.
El-Garf, Ayman http://orcid.org/0000-0001-6343-9190
Uthman, Imad http://orcid.org/0000-0001-8285-6483
Sunna, Nancy http://orcid.org/0000-0003-2088-1434
Nassier, Reenad
Mohamed, Haytham http://orcid.org/0000-0002-2883-3317
Al Saleh, Jamal
Funding for this research was provided by:
Pfizer
Article History
Received: 8 February 2019
Accepted: 3 May 2019
First Online: 27 May 2019
Compliance with ethical standards
:
: M Bedaiwi—received speaker fees from AbbVie and Pfizer Inc. I Al Homood—received speaker’s fees and advisory board honoraria from AbbVie, Lilly, Novartis and Pfizer Inc. A El-Garf—received speaker’s fees and advisory board honoraria from AbbVie, Janssen, Novartis, Pfizer Inc, Roche and UCB. I Uthman—received speaker fees from AbbVie, Janssen, Newbridge, and Pfizer Inc. J Al Saleh—received research grant from AbbVie and Pfizer Inc. N Sunna, R Nassier, and H Mohamed—employees and shareholders of Pfizer Inc.
: Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.